All Stories

  1. Regenerative Futures: From Global to Local Development in 2032
  2. An analysis of Relative Telomere Length (RTL) during chemotherapy in patients with advanced gastro-oesophageal adenocarcinoma v1
  3. An analysis of Relative Telomere Length (RTL) during peri-operative chemotherapy in patients with operable gastric or gastro-oesophageal junction adenocarcinoma v1
  4. A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length Regulation
  5. A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds
  6. Extensive telomere erosion is consistent with localised clonal expansions in Barrett’s metaplasia
  7. A multi-targeted approach to suppress tumor-promoting inflammation
  8. Broad targeting of angiogenesis for cancer prevention and therapy
  9. Broad targeting of resistance to apoptosis in cancer
  10. Cancer prevention and therapy through the modulation of the tumor microenvironment
  11. Designing a broad-spectrum integrative approach for cancer prevention and treatment
  12. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds
  13. Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
  14. Immune evasion in cancer: Mechanistic basis and therapeutic strategies
  15. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
  16. Therapeutic targeting of replicative immortality
  17. Tissue invasion and metastasis: Molecular, biological and clinical perspectives
  18. Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks
  19. Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition
  20. Plasma N-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome
  21. Immortalization of T-Cells Is Accompanied by Gradual Changes in CpG Methylation Resulting in a Profile Resembling a Subset of T-Cell Leukemias
  22. Isolation, Culture, and Transfection of Melanocytes
  23. Mathematical Model of a Telomerase Transcriptional Regulatory Network Developed by Cell-Based Screening: Analysis of Inhibitor Effects and Telomerase Expression Mechanisms
  24. A Small Molecule Modulator of Prion Protein Increases Human Mesenchymal Stem Cell Lifespan, Ex Vivo Expansion, and Engraftment to Bone Marrow in NOD/SCID Mice
  25. Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance
  26. Cancer cell senescence: a new frontier in drug development
  27. Mesenchymal Stem Cells as Therapeutic Delivery Vehicles Targeting Tumor Stroma
  28. Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms’
  29. Progeroid syndromes: models for stem cell aging?
  30. Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression
  31. Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives
  32. TCEAL7 Inhibition of c-Myc Activity in Alternative Lengthening of Telomeres Regulates hTERT Expression
  33. Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures
  34. Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in pe...
  35. Modulation of Gene Expression Using Zinc Finger-Based Artificial Transcription Factors
  36. Mining Cellular Senescence for Drug Targets
  37. A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT
  38. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma
  39. Dynamic Telomerase Gene Suppression via Network Effects of GSK3 Inhibition
  40. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms
  41. A systems biology approach to Down syndrome: Identification of Notch/Wnt dysregulation in a model of stem cells aging
  42. A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A
  43. Silencing of the expression of pluripotent driven-reporter genes stably transfected into human pluripotent cells
  44. High level of telomerase RNA gene expression is associated with chromatin modification, the ALT phenotype and poor prognosis in liposarcoma
  45. Downregulation of Multiple Stress Defense Mechanisms During Differentiation of Human Embryonic Stem Cells
  46. Targeting telomerase for cancer therapeutics
  47. Targeting Telomerase: Therapeutic Options for Cancer Treatment
  48. Telomerase redefined: Integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity
  49. Stem cell ageing: does it happen and can we intervene?
  50. Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells
  51. Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart
  52. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention
  53. Modulation of Telomerase Promoter Tumor Selectivity in the Context of Oncolytic Adenoviruses
  54. Cancer stem cells: Opportunities for novel diagnostics and drug discovery
  55. Therapeutic potential of adult stem cells
  56. Transcriptional Repression of Telomerase RNA Gene Expression by c-Jun-NH2-Kinase and Sp1/Sp3
  57. Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell
  58. Properties of a Telomerase-Specific Cre/Lox Switch for Transcriptionally Targeted Cancer Gene Therapy
  59. Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms
  60. Synthetic Anticancer Gene Medicine Exploits Intrinsic Antitumor Activity of Cationic Vector to Cure Established Tumors
  61. Lack of Telomerase Gene Expression in Alternative Lengthening of Telomere Cells Is Associated with Chromatin Remodeling of thehTRandhTERTGene Promoters
  62. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
  63. The hTERT and hTERC Telomerase Gene Promoters Are Activated by the Second Exon of the Adenoviral Protein, E1 A, Identifying the Transcriptional Corepressor CtBP as a Potential Rearessor of Both Genes
  64. Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic Algorithm
  65. Application of Targeted Radiotherapy/Gene Therapy to Bladder Cancer Cell Lines
  66. Dysregulated expression of the major telomerase components in leukaemic stem cells
  67. MDM2 negatively regulates the human telomerase RNA gene promoter
  68. Drug Insight: cancer cell immortality—telomerase as a target for novel cancer gene therapies
  69. Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate
  70. An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects
  71. A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria
  72. Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation
  73. From stem cells to cancer: balancing immortality and neoplasia
  74. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach
  75. Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase
  76. Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene
  77. Why a Special Issue on Gene Therapy?
  78. Telomerase-directed molecular therapeutics
  79. ?Senescence-associated? ?-galactosidase activity in the upper gastrointestinal tract
  80. Somatic cell hybrids
  81. Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization
  82. Genetic Analysis of Drug Resistance by Reverse In Situ Hybridization
  83. Detection of Telomerase Enzyme Activity by TRAP Assay
  84. Detection of Telomerase hTERT Gene Expression and Its Splice Variants by RT-PCR